Bold Therapeutics Selected as 2023 'Company to Watch' by Life Sciences British Columbia
/PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, is announcing its selection by Life...
Source: prnewswire.com